Literature DB >> 6882256

The clinical value of negative temporal artery biopsy specimens.

T R Hedges, G L Gieger, D M Albert.   

Abstract

The clinical course of patients with signs and symptoms suggestive of temporal arteritis but with negative temporal artery biopsy specimens was evaluated. Ninety-one patients undergoing a biopsy formed the basis of this study. Of these, 63 patients had no evidence of arteritis on biopsy, and 28 patients had biopsy specimens showing granulomatous inflammation. False-negative findings from biopsy specimens occurred in 5% of patients who had the disease. Cancer was the final diagnosis in 21% of patients with negative biopsy specimens v 3% of patients with temporal arteritis. Various chronic systemic inflammatory diseases were found in 16% of patients with negative biopsy specimens, while none of the patients with temporal arteritis had additional systemic inflammatory diseases. Patients with proven arteritis were notably older and had higher ESRs than patients without the disease. However, no laboratory test or frequently observed symptom or sign noted on initial examination, considered alone or in combination with other findings, had diagnostic sensitivity or specificity as high as temporal artery biopsy.

Entities:  

Mesh:

Year:  1983        PMID: 6882256     DOI: 10.1001/archopht.1983.01040020253019

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  10 in total

1.  Surgical performance for specialties undertaking temportal artery biopsies: who should perform them?

Authors:  Gavin D Galloway; Bernhard Klebe; Paul Riordan-Eva
Journal:  Br J Ophthalmol       Date:  2002-02       Impact factor: 4.638

2.  Temporal artery biopsy in the management of giant cell arteritis with neuro-ophthalmic complications.

Authors:  P Riordan-Eva; K Landau; J O'Day
Journal:  Br J Ophthalmol       Date:  2001-10       Impact factor: 4.638

3.  [Magnetic resonance angiography in rheumatology].

Authors:  T A Bley; B Ostendorf; A Scherer; H Kellner; W A Schmidt
Journal:  Z Rheumatol       Date:  2012-07       Impact factor: 1.372

4.  Clinical usefulness of temporal artery biopsy.

Authors:  J Vilaseca; A González; M C Cid; J Lopez-Vivancos; A Ortega
Journal:  Ann Rheum Dis       Date:  1987-04       Impact factor: 19.103

5.  Histological parameters helpful in recognising steroid-treated temporal arteritis: an analysis of 35 cases.

Authors:  Ramon L Font; Venkatesh C Prabhakaran
Journal:  Br J Ophthalmol       Date:  2006-09-20       Impact factor: 4.638

6.  Effect of prior steroid treatment on temporal artery biopsy findings in giant cell arteritis.

Authors:  N Ray-Chaudhuri; D Ah Kiné; S O Tijani; D V Parums; N Cartlidge; N P Strong; M R Dayan
Journal:  Br J Ophthalmol       Date:  2002-05       Impact factor: 4.638

7.  Negative temporal artery biopsy: predictive factors for giant cell arteritis diagnosis and alternate diagnoses of patients without arteritis.

Authors:  Gil Bornstein; Iris Barshack; Nira Koren-Morag; Ilan Ben-Zvi; Nadav Furie; Chagai Grossman
Journal:  Clin Rheumatol       Date:  2018-03-17       Impact factor: 2.980

8.  Diagnostic Assessment Strategies and Disease Subsets in Giant Cell Arteritis: Data From an International Observational Cohort.

Authors:  K Bates Gribbons; Cristina Ponte; Anthea Craven; Joanna C Robson; Ravi Suppiah; Raashid Luqmani; Richard Watts; Peter A Merkel; Peter C Grayson
Journal:  Arthritis Rheumatol       Date:  2020-03-05       Impact factor: 15.483

9.  The Utility of Color Duplex Ultrasonography in the Diagnosis of Giant Cell Arteritis: A Prospective, Masked Study. (An American Ophthalmological Society Thesis).

Authors:  Jurij R Bilyk; Ann P Murchison; Benjamin T Leiby; Robert C Sergott; Ralph C Eagle; Laurence Needleman; Peter J Savino
Journal:  Trans Am Ophthalmol Soc       Date:  2018-06-25

10.  Diagnostic Accuracy of Symptoms, Physical Signs, and Laboratory Tests for Giant Cell Arteritis: A Systematic Review and Meta-analysis.

Authors:  Kornelis S M van der Geest; Maria Sandovici; Elisabeth Brouwer; Sarah L Mackie
Journal:  JAMA Intern Med       Date:  2020-10-01       Impact factor: 21.873

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.